日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies

新型PI3Kδ抑制剂roginolisib与venetoclax在血液系统恶性肿瘤中具有协同作用

Sasi, Binu Kandathilparambil; Tarantelli, Chiara; Martindale, Stephen; Civanelli, Elisa; Cannas, Eleonora; Sartori, Giulio; Arribas, Alberto J; Fernandes, Stacey M; Shupe, Samantha J; Machado, John-Hanson; Tyekucheva, Svitlana; Ren, Yue; Lahn, Michael; Van der Veen, Lars; Di Conza, Giusy; Bertoni, Francesco; Brown, Jennifer R

KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.

KAT/3BP:一种针对代谢的靶向药物,对侵袭性 B 细胞淋巴瘤具有单药和联合治疗活性

Tarantelli Chiara, Spriano Filippo, Civanelli Elisa, Aresu Luca, Risi Giorgia, Cannas Eleonora, Kayali Omar, Cascione Luciano, Arribas Alberto J, Stathis Anastasios, Ko Young H, Bertoni Francesco

Targeting CD19-positive lymphomas with the antibodydrug conjugate loncastuximab tesirine: preclinical evidence of activity as a single agent and in combination therapy

使用抗体药物偶联物loncastuximab tesirine靶向CD19阳性淋巴瘤:单药及联合治疗的临床前活性证据

Tarantelli, Chiara; Wald, David; Munz, Nicolas; Spriano, Filippo; Bruscaggin, Alessio; Cannas, Eleonora; Cascione, Luciano; Gaudio, Eugenio; Arribas, Alberto J; Manjappa, Shivaprasad; Golino, Gaetanina; Scalise, Lorenzo; Cacciapuoti, Maria Teresa; Zucca, Emanuele; Stathis, Anastasios; Inghirami, Giorgio; Van Berkel, Patrick H; Rossi, Davide; Caimi, Paolo F; Zammarchi, Francesca; Bertoni, Francesco

A first-in-class Wiskott-Aldrich syndrome protein activator with antitumor activity in hematologic cancers

一种首创的Wiskott-Aldrich综合征蛋白激活剂,对血液肿瘤具有抗肿瘤活性

Spriano, Filippo; Sartori, Giulio; Sgrignani, Jacopo; Barnabei, Laura; Arribas, Alberto J; Guala, Matilde; Del Amor, Ana Maria Carrasco; Tomasso, Meagan R; Tarantelli, Chiara; Cascione, Luciano; Golino, Gaetanina; Riveiro, Maria E; Bortolozzi, Roberta; Lupia, Antonio; Paduano, Francesco; Huguet, Samuel; Rezai, Keyvan; Rinaldi, Andrea; Margheriti, Francesco; Ventura, Pedro; Guarda, Greta; Costa, Giosuè; Rocca, Roberta; Furlan, Alberto; Verdonk, Luuk M; Innocenti, Paolo; Martin, Nathaniel I; Viola, Giampietro; Driessen, Christoph; Zucca, Emanuele; Stathis, Anastasios; Gahtory, Digvijay; Van den Nieuwboer, Maurits; Bornhauser, Beat; Alcaro, Stefano; Trapasso, Francesco; Cristobal, Susana; Padrick, Shae B; Pazzi, Natalina; Cavalli, Franco; Cavalli, Andrea; Gaudio, Eugenio; Bertoni, Francesco

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

PI3Kδ激活、IL-6过表达和CD37缺失导致淋巴瘤对那拉妥昔单抗-美坦新产生耐药性

Arribas, Alberto J; Napoli, Sara; Gaudio, Eugenio; Herbaux, Charles; Cannas, Eleonora; Tarantelli, Chiara; Bordone-Pittau, Roberta; Cascione, Luciano; Munz, Nicolas; Aresu, Luca; Sgrignani, Jacopo; Rinaldi, Andrea; Kwee, Ivo; Rossi, Davide; Cavalli, Andrea; Zucca, Emanuele; Stussi, Georg; Stathis, Anastasios; Sloss, Callum; Davids, Matthew S; Bertoni, Francesco

ADCT-602, a Novel PBD Dimer-containing Antibody-Drug Conjugate for Treating CD22-positive Hematologic Malignancies

ADCT-602,一种新型含 PBD 二聚体的抗体药物偶联物,用于治疗 CD22 阳性血液系统恶性肿瘤

Francesca Zammarchi, Karin E Havenith, Nikoleta Sachini, Narinder Janghra, Simon Chivers, Esohe Idusogie, Eugenio Gaudio, Chiara Tarantelli, Francois Bertelli, Kathleen Santos, Peter Tyrer, Simon Corbett, Filippo Spriano, Gaetanina Golino, Luciano Cascione, Francesco Bertoni, John A Hartley, Patrick

The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib

ATR 抑制剂 elimusertib 具有抗淋巴瘤活性,并与 PI3K 抑制剂 copanlisib 产生协同作用

Giulio Sartori, Chiara Tarantelli, Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Michele Mascia, Marilia Barreca, Alberto J Arribas, Luca Licenziato, Gaetanina Golino, Adele Ferragamo, Stefano Pileri, Giovanna Damia, Emanuele Zucca, Anastasios Stathis, Oliver Politz, Antje M Wengner, Francesco

Thinking Outside the Box: Indirect Myc Modulation in Canine B-Cell Lymphoma

跳出思维定式:犬 B 细胞淋巴瘤的间接 Myc 调节

Luca Licenziato, Eugenio Mazzone, Chiara Tarantelli, Paolo Accornero, Andrea Rinaldi, Sara Divari, Wilfred Leung, Suzin Webb, Raffaella De Maria, Luca Aresu

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors

使用 Emavusertib 靶向治疗对 PI3K 和 BTK 抑制剂具有继发性耐药性的淋巴瘤模型中的 IRAK4

Francesca Guidetti, Alberto J Arribas, Giulio Sartori, Filippo Spriano, Laura Barnabei, Chiara Tarantelli, Reinhard Von Roemeling, Elizabeth Martinez, Emanuele Zucca, Francesco Bertoni

IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

IOA-244 是一种非 ATP 竞争性、高选择性、耐受性好的 PI3K Delta 抑制剂,可靶向实体肿瘤并打破免疫耐受性

Zoë Johnson #, Chiara Tarantelli #, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni #, Lars van der Veen, Giusy